Medindia

X

QIAGEN Hereditary and Rare Disease Solution Chosen by Genomics England

Tuesday, January 31, 2017 General News J E 4
Advertisement

HILDEN, Germany and LONDON, January 30, 2017 /PRNewswire/ --

Bioinformatics content knowledgebase will enable interpretation for 100,000 Genomes Project 

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that Genomics England has selected QIAGEN's HGMDŪ Human Gene Mutation Database for its 100,000 Genomes Project. HGMD is the leading content knowledgebase for interpretation of genomic data in hereditary and rare diseases, providing a deep resource of expertly curated data from the world's scientific and clinical literature.

The 100,000 Genomes Project will use QIAGEN's HGMD Online Professional solution, which is part of the QIAGEN Clinical Insight (QCI) portfolio of solutions for the interpretation of complex genomic data, to support scientists, clinicians and researchers in 13 NHS Genomic Medicine Centres for clinical reporting and interpretation.

"Rare and hereditary diseases can lock patients, families and healthcare providers in a long, difficult diagnostic odyssey, and 100,000 Genomes is a cutting-edge NHS program to gather and analyze whole genomes from a large cohort of patients in search of causes and future treatments," said Dr. Laura Furmanski, Senior Vice President and Head of QIAGEN's Bioinformatics Business Area. "We are honored to deepen our collaboration with Genomics England. QIAGEN's industry-leading bioinformatics solutions, including cloud-based HGMD content, will help 100,000 Genomes derive actionable insights from a massive pool of next-generation sequencing data. We are pleased to be selected."

Click here for the full press release

https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID={B0DDBFB1-EDEC-4F32-9354-91CD3AE8FE65}&lang=en

Contacts: 

QIAGEN 

Investor Relations John Gilardi +49-2103-29-11711 e-mail: ir@QIAGEN.com Public Relations Dr. Thomas Theuringer +49-2103-29-11826 e-mail: pr@QIAGEN.com

Genomics England 

Katrina Nevin-Ridley Director of Communications Email: katrina.nevin-ridley@genomicsengland.co.uk Phone: +44(0)207-882-6493 @GenomicsEngland   #genomes100k

SOURCE QIAGEN N.V.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
AARP Illinois Launches Campaign to Protect Medicar...
S
Kroger Pharmacies to Increase Access to Naloxone i...